209
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Association Analysis of TGFBR3 Gene with Vogt-Koyanagi-Harada Disease and Behcet’s Disease in the Chinese Han Population

, , , , , & show all
Pages 312-317 | Received 04 May 2011, Accepted 13 Oct 2011, Published online: 22 Mar 2012

REFERENCES

  • Yang P, Zhang Z, Zhou H et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res. 2005;30:943–948.
  • Yang P, Ren Y, Li B, Fang W, Meng Q, Kijlstra A. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology. 2007;114:606–614.
  • Andreoli CM, Foster CS. Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin. 2006;46:111–122.
  • Forster DJ, Cano MR, Green RL, Rao NA. Echographic features of the Vogt-Koyanagi-Harada syndrome. Arch Ophthalmol. 1990;108:1421–1426.
  • Keino H, Okada AA. Behçet’s disease: Global epidemiology of an old silk road disease. Br J Ophthalmol. 2007;91:1573–1574.
  • Sakane T, Takeno M, Suzuki N, Inaba G. Behçet’s disease. N Engl J Med. 1999;341:1284–1291.
  • Yang P, Fang W, Meng Q, Ren Y, Xing L, Kijlstra A. Clinical features of chinese patients with Behçet’s disease. Ophthalmology. 2008;115:312–318.
  • Fresko I, Soy M, Hamuryudan V et al. Genetic anticipation in Behçet’s syndrome. Ann Rheum Dis. 1998;57:45–48.
  • Ohno S. Immunological aspects of Behçet’s and Vogt-Koyanagi-Harada’s diseases. Trans Ophthalmol Soc UK. 1981;101:335–341.
  • Mizuki N, Ota M, Yabuki K, Katsuyama Y, Ando H, Palimeris GD et al. Localization of the pathogenic gene of Behcet’s disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci. 2000;41:3702–3708.
  • Yamaki K, Gocho K, Hayakawa K, Kondo I, Sakuragi S. Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease. J Immunol. 2000;165:7323–7329.
  • Dilek K, Ozçimen AA, Saricaoglu H et al. Cytokine gene polymorphisms in Behçet’s disease and their association with clinical and laboratory findings. Clin Exp Rheumatol. 2009;27:73–78.
  • Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet’s disease susceptibility loci. Nat gene. 2010;42:703–706.
  • Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet’s disease. Nat genet. 2010;42:698–702.
  • Chi W, Yang P, Li B et al. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol. 2007;119:1218–1224.
  • Chi W, Zhu X, Yang P et al. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. Invest Ophthalmol Vis Sci. 2008;49:3058–3064.
  • O’Garra A, Stockinger B, Veldhoen M. Differentiation of human T(H)-17 cells does require TGF-β! Nat Immunol. 2008;9:588–590.
  • Mangan PR, Harrington LE, O’Quinn DB et al. Transforming growth factor-β induces development of the T(H)17 lineage. Nature. 2006;441:231–234.
  • Manel N, Unutmaz D, Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORgammat. Nat Immunol. 2008;9:641–649.
  • Kang JS, Liu C, Derynck R. New regulatory mechanisms of TGF-β receptor function. Trends Cell Biol. 2009;19:385–394.
  • Massagué J, Blain SW, Lo RS. TGFβ signaling in growth control, cancer, and heritable disorders. Cell. 2000;103:295–309.
  • You HJ, How T, Blobe GC. The type III transforming growth factor-β receptor negatively regulates nuclear factor κ B signaling through its interaction with β-arrestin2. Carcinogenesis. 2009;30:1281–1287.
  • Blobe GC, Schiemann WP, Pepin MC et al. Functional roles for the cytoplasmic domain of the type III transforming growth factor β receptor in regulating transforming growth factor β signaling. J Biol Chem. 2001;276:24627–24637.
  • Xiong DH, Liu XG, Guo YF, Tan LJ, Wang L, Sha BY et al. Genome-wide association and follow-up replication studies identified ADAMTS18 and TGFBR3 as bone mass candidate genes in different ethnic groups. Am J Hum Genet. 2009;84:388–398.
  • Kim HK, Jang TW, Jung MH et al. Association between genetic variations of the transforming growth factor β receptor type III and asthma in a Korean population. Exp Mol Med. 2010;42:420–427.
  • Read RW, Holland GN, Rao NA et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: Report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647–652.
  • Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s disease. Lancet. 1990;335:1078–1080.
  • Japan BsDRco. The Revised Criteria and Manual of Treatments of Behcet’s disease. Tokyo: Ministry of Health and Welfare. 2003:11–29. is corrected as “Behcet’s Disease Research Committee of Japan: The Revised Criteria and Manual of Treatments of Behcet’s Disease. Ministry of Health and Welfare 2003. Tokyo, Japan; 11, 2003.
  • Shindo Y, Ohno S, Nakamura S, Onoé K, Inoko H. A significant association of HLA-DPB1*0501 with Vogt-Koyanagi-Harada’s disease results from a linkage disequilibrium with the primarily associated allele, DRB1*0405. Tissue Antigens. 1996;47:344–345.
  • Zhao M, Jiang Y, Abrahams IW. Association of HLA antigens with Vogt-Koyanagi-Harada syndrome in a Han Chinese population. Arch Ophthalmol. 1991;109:368–370.
  • Mizuki N, Ota M, Katsuyama Y et al. Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet’s disease. Arthritis Rheum. 1999;42:1961–1966.
  • Mizuki N, Inoko H, Ando H et al. Behçet’s disease associated with one of the HLA-B51 subantigens, HLA-B* 5101. Am J Ophthalmol. 1993;116:406–409.
  • Mizuki N, Yabuki K, Ota M et al. Analysis of microsatellite polymorphism around the HLA-B locus in Iranian patients with Behçet’s disease. Tissue Antigens. 2002;60:396–399.
  • Mizuki N, Ota M, Katsuyama Y et al. Sequencing-based typing of HLA-B*51 alleles and the significant association of HLA-B*5101 and -B*5108 with Behçet’s disease in Greek patients. Tissue Antigens. 2002;59:118–121.
  • Horie Y, Kitaichi N, Takemoto Y et al. Polymorphism of IFN-γ gene and Vogt-Koyanagi-Harada disease. Mol Vis. 2007;13:2334–2338.
  • Jiang Z, Yang P, Hou S, Li F, Zhou H. Polymorphisms of IL23R and Vogt-Koyanagi-Harada syndrome in a Chinese Han population. Hum Immunol. 2010;71:414–417.
  • Du L, Yang P, Hou S et al. Association of the CTLA-4 gene with Vogt-Koyanagi-Harada syndrome. Clin Immunol. 2008;127:43–48.
  • Hou S, Yang P, Du L et al. Small ubiquitin-like modifier 4 (SUMO4) polymorphisms and Vogt-Koyanagi-Harada (VKH) syndrome in the Chinese Han population. Mol Vis. 2008;14:2597–2603.
  • Hou S, Yang P, Du L et al. SUMO4 gene polymorphisms in Chinese Han patients with Behcet’s disease. Clin Immunol. 2008;129:170–175.
  • Li K, Yang P, Zhao M et al. Polymorphisms of FCRL3 in a Chinese population with Vogt-Koyanagi-Harada (VKH) syndrome. Mol Vis. 2009;15:955–961.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.